Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PTLA

Portola Pharmaceuticals

$41.22

-2.07 (-4.78%)

07:16
06/14/18
06/14
07:16
06/14/18
07:16
Recommendations
Portola Pharmaceuticals analyst commentary at Citi »

Portola not planning sale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTLA

Portola Pharmaceuticals

$40.77

0.02 (0.05%)

16:33
06/04/18
06/04
16:33
06/04/18
16:33
Hot Stocks
Portola Pharmaceuticals CEO William Lis to retire in 2018 »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

PTLA

Portola Pharmaceuticals

$40.75

0.53 (1.32%)

08:51
06/04/18
06/04
08:51
06/04/18
08:51
Hot Stocks
Portola Pharmaceuticals reports ORR of 47% in Phase 2a cerdulatinib study »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

PTLA

Portola Pharmaceuticals

$39.48

-0.71 (-1.77%)

08:34
05/24/18
05/24
08:34
05/24/18
08:34
Hot Stocks
Portola Pharma receives $100M milestone payment from HealthCare Royalty »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

CLVS

Clovis

$48.22

-1.71 (-3.42%)

, GILD

Gilead

$68.15

0.3 (0.44%)

04:55
05/24/18
05/24
04:55
05/24/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$48.22

-1.71 (-3.42%)

GILD

Gilead

$68.15

0.3 (0.44%)

PTLA

Portola Pharmaceuticals

$39.48

-0.71 (-1.77%)

DNLI

Denali Therapeutics

$20.33

0.32 (1.60%)

TBPH

Theravance Biopharma

$23.01

0.04 (0.17%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.70

0.1 (1.16%)

NKTR

Nektar

$82.81

0.87 (1.06%)

BMRN

BioMarin

$88.50

0.84 (0.96%)

RARE

Ultragenyx

$65.28

1.07 (1.67%)

EXEL

Exelixis

$20.59

-0.99 (-4.59%)

ANAB

AnaptysBio

$81.93

-4.25 (-4.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

CLVS

Clovis

$49.93

0.24 (0.48%)

, GILD

Gilead

$67.85

0.22 (0.33%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$49.93

0.24 (0.48%)

GILD

Gilead

$67.85

0.22 (0.33%)

PTLA

Portola Pharmaceuticals

$40.19

-0.76 (-1.86%)

DNLI

Denali Therapeutics

$20.01

0.32 (1.63%)

TBPH

Theravance Biopharma

$22.97

-0.03 (-0.13%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.60

-0.1 (-1.15%)

NKTR

Nektar

$81.94

-1.46 (-1.75%)

BMRN

BioMarin

$87.66

-1.69 (-1.89%)

RARE

Ultragenyx

$64.21

-0.55 (-0.85%)

EXEL

Exelixis

$21.58

0.64 (3.06%)

ANAB

AnaptysBio

$86.18

-0.72 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

CLVS

Clovis

$49.69

-0.43 (-0.86%)

, GILD

Gilead

$67.63

-0.38 (-0.56%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$49.69

-0.43 (-0.86%)

GILD

Gilead

$67.63

-0.38 (-0.56%)

PTLA

Portola Pharmaceuticals

$40.95

-0.45 (-1.09%)

DNLI

Denali Therapeutics

$19.69

-0.02 (-0.10%)

TBPH

Theravance Biopharma

$23.00

-1.27 (-5.23%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.70

-0.425 (-4.66%)

NKTR

Nektar

$83.40

-1.9 (-2.23%)

BMRN

BioMarin

$89.35

0.4 (0.45%)

RARE

Ultragenyx

$64.76

-1.17 (-1.77%)

EXEL

Exelixis

$20.94

-0.64 (-2.97%)

ANAB

AnaptysBio

$86.90

-0.52 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

Over a month ago
CLVS

Clovis

$50.12

-1.89 (-3.63%)

, GILD

Gilead

$68.01

0.41 (0.61%)

07:15
05/21/18
05/21
07:15
05/21/18
07:15
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$50.12

-1.89 (-3.63%)

GILD

Gilead

$68.01

0.41 (0.61%)

PTLA

Portola Pharmaceuticals

$41.40

0.4 (0.98%)

DNLI

Denali Therapeutics

$19.71

0.72 (3.79%)

TBPH

Theravance Biopharma

$24.27

-0.19 (-0.78%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$9.13

0.025 (0.27%)

NKTR

Nektar

$85.30

6.075 (7.67%)

BMRN

BioMarin

$88.95

0.51 (0.58%)

RARE

Ultragenyx

$65.93

1.75 (2.73%)

EXEL

Exelixis

$21.58

0.02 (0.09%)

ANAB

AnaptysBio

$87.42

-1.92 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

PTLA

Portola Pharmaceuticals

$42.22

-0.14 (-0.33%)

16:39
05/09/18
05/09
16:39
05/09/18
16:39
Earnings
Portola Pharmaceuticals reports Q1 EPS ($1.28), consensus ($1.54) »

Reports Q1 revenue $6.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 21

    May

  • 12

    Jun

PTLA

Portola Pharmaceuticals

$42.45

8.67 (25.67%)

07:54
05/07/18
05/07
07:54
05/07/18
07:54
Recommendations
Portola Pharmaceuticals analyst commentary at Morgan Stanley »

Portola price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 21

    May

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.